These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12769700)

  • 1. Predicting passive transport in silico--history, hype, hope.
    Clark DE; Grootenhuis PD
    Curr Top Med Chem; 2003; 3(11):1193-203. PubMed ID: 12769700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From drug target to leads--sketching a physicochemical pathway for lead molecule design in silico.
    Shaikh SA; Jain T; Sandhu G; Latha N; Jayaram B
    Curr Pharm Des; 2007; 13(34):3454-70. PubMed ID: 18220783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico identification of bioisosteric functional groups.
    Ertl P
    Curr Opin Drug Discov Devel; 2007 May; 10(3):281-8. PubMed ID: 17554854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational chemistry as an integral component of lead generation.
    Roche O; Guba W
    Mini Rev Med Chem; 2005 Jul; 5(7):677-83. PubMed ID: 16026314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent development and application of virtual screening in drug discovery: an overview.
    Hou T; Xu X
    Curr Pharm Des; 2004; 10(9):1011-33. PubMed ID: 15078130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building predictive ADMET models for early decisions in drug discovery.
    Penzotti JE; Landrum GA; Putta S
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):49-61. PubMed ID: 14982148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of high-throughput technologies in pharmaceutics].
    Bai XL; Gao YL
    Yao Xue Xue Bao; 2006 Jun; 41(6):487-92. PubMed ID: 16927820
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful drug discovery.
    Swinney DC
    Curr Top Med Chem; 2006; 6(5):403-4. PubMed ID: 16719799
    [No Abstract]   [Full Text] [Related]  

  • 9. From in vivo to in vitro/in silico ADME: progress and challenges.
    Van de Waterbeemd H
    Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):1-4. PubMed ID: 16922647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-based drug design methodologies in drug discovery process: an overview.
    Bacilieri M; Moro S
    Curr Drug Discov Technol; 2006 Sep; 3(3):155-65. PubMed ID: 17311561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards integrated ADME prediction: past, present and future directions for modelling metabolism by UDP-glucuronosyltransferases.
    Smith PA; Sorich MJ; Low LS; McKinnon RA; Miners JO
    J Mol Graph Model; 2004 Jul; 22(6):507-17. PubMed ID: 15182810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico prediction of ADME and pharmacokinetics. Report of an expert meeting organised by COST B15.
    Boobis A; Gundert-Remy U; Kremers P; Macheras P; Pelkonen O
    Eur J Pharm Sci; 2002 Dec; 17(4-5):183-93. PubMed ID: 12453607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR and QM/MM approaches applied to drug metabolism prediction.
    Braga RC; Andrade CH
    Mini Rev Med Chem; 2012 Jun; 12(6):573-82. PubMed ID: 22587770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
    Tropsha A; Golbraikh A
    Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Silico Absorption, Distribution, Metabolism, Excretion, and Pharmacokinetics (ADME-PK): Utility and Best Practices. An Industry Perspective from the International Consortium for Innovation through Quality in Pharmaceutical Development.
    Lombardo F; Desai PV; Arimoto R; Desino KE; Fischer H; Keefer CE; Petersson C; Winiwarter S; Broccatelli F
    J Med Chem; 2017 Nov; 60(22):9097-9113. PubMed ID: 28609624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico prediction of blood-brain barrier permeation.
    Clark DE
    Drug Discov Today; 2003 Oct; 8(20):927-33. PubMed ID: 14554156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Silico and Ex silico ADME approaches for drug discovery.
    Darvas F; Keseru G; Papp A; Dormán G; Urge L; Krajcsi P
    Curr Top Med Chem; 2002 Dec; 2(12):1287-304. PubMed ID: 12470281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite identification and profiling in drug design: current practice and future directions.
    Zhang Z; Zhu M; Tang W
    Curr Pharm Des; 2009; 15(19):2220-35. PubMed ID: 19601824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives of pharmacokinetics and metabolism in drug design.
    Hsieh Y
    Curr Pharm Des; 2009; 15(19):2169. PubMed ID: 19601820
    [No Abstract]   [Full Text] [Related]  

  • 20. Physicochemical property trends of marketed prodrugs.
    Landis MS
    Ther Deliv; 2013 Feb; 4(2):225-37. PubMed ID: 23343161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.